-+ 0.00%
-+ 0.00%
-+ 0.00%

Aspira Women's Health to Restate Financial Reports Over Cash Flow Classification Errors

PUBT·11/16/2026 22:09:02
Listen to the news
Aspira Women's Health to Restate Financial Reports Over Cash Flow Classification Errors
  • Aspira Women's Health will restate financial statements for the three months ended March 31 and six months ended June 30, 2026.
  • The audit committee determined on November 13, 2026, that those statements should no longer be relied upon because of material cash-flow errors.
  • Loan proceeds and related payments were misclassified as operating rather than financing activities; total cash changes were unaffected.
  • Management identified a material weakness, concluding that financial reporting controls and disclosure procedures were ineffective for both periods.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aspira Women's Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000926617-26-000058), on November 16, 2026, and is solely responsible for the information contained therein.